Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

MGRX - MANGOCEUTICALS, INC.


3.18
-0.020   -0.629%

Share volume: 67,236
Last Updated: Tue 04 Feb 2025 10:00:00 PM CET

PREVIOUS CLOSE
CHG
CHG%

$3.20
0.07
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
5.12%
1 Month
20.00%
3 Months
28.23%
6 Months
808.83%
1 Year
675.61%
2 Year
-20.50%
Key data
Stock price
$3.18
P/E Ratio 
0.00
DAY RANGE
$3.01 - $3.22
EPS 
-$2.92
52 WEEK RANGE
$0.14 - $3.22
52 WEEK CHANGE
$691.04
MARKET CAP 
7.058 M
YIELD 
N/A
SHARES OUTSTANDING 
29.906 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
-0.46
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$58,391
AVERAGE 30 VOLUME 
$56,689
Company detail
CEO: Jacob D. Cohen
Region: US
Website: www.mangorx.com
Employees: 0
IPO year: 2023
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

We plan to connect consumers to licensed healthcare professionals through our recently launched website at www.MangoRX.com for the provision of care via telehealth on our customer portal and plan to also provide access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. Our principal executive offices are located in Dallas, Texas.

Recent news